Author:
Gómez Ana María,Henao Carrillo Diana Cristina,Ré Matías Alberto,Faradji Raquel N.,Flores Caloca Oscar,de la Garza Hernández Natalia Eloísa,Antillón Ferreira Carlos,Garnica-Cuéllar Juan C.,Krakauer Marcio,Galindo Rodolfo J.
Abstract
Abstract
Background
Continuous glucose monitoring can improve glycemic control for hospitalized patients with diabetes, according to current evidence. However, there is a lack of consensus-established recommendations for the management of hospitalized patients with diabetes using flash continuous glucose monitoring system (fCGM) in Latin America. Therefore, this expert consensus exercise aimed to establish guidelines on the implementation of fCGM in the management of hospitalized patients with diabetes in Latin America.
Methods
The modified Delphi method was applied on a panel of nine specialists, establishing consensus at 80%. A twenty-two-question instrument was developed to establish recommendations on the use of fCGM in hospitalized patients living with diabetes.
Results
Based on consensus, experts recommend the use of fCGM in hospitalized patients with diabetes starting at admission or whenever hyperglycemia (> 180 mg/dl) is confirmed and continue monitoring throughout the entire hospital stay. The recommended frequency of fCGM scans varies depending on the patient's age and diabetes type: ten scans per day for pediatric patients with type 1 and 2 diabetes, adult patients with type 1 diabetes and pregnant patients, and seven scans for adult patients with type 2 diabetes. Different hospital services can benefit from fCGM, including the emergency room, internal medicine departments, intensive care units, surgery rooms, and surgery wards.
Conclusions
The use of fCGM is recommended for patients with diabetes starting at the time of admission in hospitals in Latin America, whenever the necessary resources (devices, education, personnel) are available.
Publisher
Springer Science and Business Media LLC
Reference16 articles.
1. Avari P, Lumb A, Flanagan D, Rayman G, Misra S, Dhatariya K, et al. Continuous glucose monitoring within hospital: a scoping review and summary of guidelines from the joint British diabetes societies for inpatient care. J Diabet Sci Technol. 2023;17(3):611–24. https://doi.org/10.1177/19322968221137338.
2. Pérez AP, Gutiérrez PC, Diosdado MA, Martínez VB, Anuncibay PG, de Casasola GG, et al. Treatment of hyperglycemia in hospital settings. Med Clín. 2009;132(12):465–75.
3. Camacho-Saavedra LA. Hyperglycemia as a mortality prognosis factor in patients with SARS-CoV-2. Rev De La Soc Peru De Med Int. 2020;33(4):151–4.
4. Zelada H, Perez-Guzman MC, Chernavvsky DR, Galindo RJ. Continuous glucose monitoring for inpatient diabetes management: an update on current evidence and practice. Endocr Conn. 2023;12(10): e230180. https://doi.org/10.1530/EC-23-0180.
5. Fortmann AL, Spierling Bagsic SR, Talavera L, Garcia IM, Sandoval H, Hottinger A, et al. Glucose as the fifth vital sign: a randomized controlled trial of continuous glucose monitoring in a non-ICU hospital setting. Diabet Care. 2020;43(11):2873–7. https://doi.org/10.2337/dc20-1016.